Late stages of hematopoiesis and B cell lymphopoiesis are regulated by α-synuclein, a key player in Parkinson's disease
- 1 November 2014
- journal article
- Published by Elsevier in Immunobiology
- Vol. 219 (11) , 836-844
Abstract
No abstract availableKeywords
Funding Information
- Office of Diversity and Inclusion
- University Hospitals Case Medical Center, Cleveland, OH
This publication has 51 references indexed in Scilit:
- Properties of native brain α-synucleinNature, 2013
- Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2eLife, 2013
- Large α-synuclein oligomers inhibit neuronal SNARE-mediated vesicle dockingProceedings of the National Academy of Sciences, 2013
- αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunctionProceedings of the National Academy of Sciences, 2010
- From hematopoietic progenitors to B cells: mechanisms of lineage restriction and commitmentCurrent Opinion in Immunology, 2010
- Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after EndocytosisNeuron, 2010
- Tumor Suppression by Phospholipase C-β3 via SHP-1-Mediated Dephosphorylation of Stat5Cancer Cell, 2009
- Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disordersActa Neuropathologica, 2008
- Nitrated Alpha-Synuclein and Microglial Neuroregulatory ActivitiesJournal of Neuroimmune Pharmacology, 2008
- Autoantibodies to alpha‐synuclein in inherited Parkinson’s diseaseJournal of Neurochemistry, 2006